BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brand BA, Haveman YRA, de Beer F, de Boer JN, Dazzan P, Sommer IEC. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol Med 2021;:1-15. [PMID: 34763737 DOI: 10.1017/S0033291721004591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lefebvre A, Pouchon A, Bioulac S, Mallet J, Polosan M, Dondé C. Management of schizophrenia in women during the perinatal period: a synthesis of international recommendations. Expert Opin Pharmacother 2022. [PMID: 35835161 DOI: 10.1080/14656566.2022.2102421] [Reference Citation Analysis]
2 Santos S, Ferreira H, Martins J, Gonçalves J, Castelo-branco M. Male sex bias in early and late onset neurodevelopmental disorders: shared aspects and differences in autism spectrum disorder, attention deficit/hyperactivity disorder, and schizophrenia. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 Brand BA, de Boer JN, Dazzan P, Sommer IE. Towards better care for women with schizophrenia-spectrum disorders. The Lancet Psychiatry 2022. [DOI: 10.1016/s2215-0366(21)00383-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sabesan P, Kasianandan A, Palaniyappan L. Prescribing differently for women with first-episode psychosis. J Psychiatry Neurosci 2021;46:E711. [PMID: 34933942 DOI: 10.1503/jpn.210216] [Reference Citation Analysis]